NCT05353205 2022-04-29
A Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 4 Unknown
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Shenzhen Second People's Hospital